Globe Life Inc. (GL) is a Financials stock trading at $173.08 (as of 2026-08-24), with a market capitalization of $13.30B and a trailing P/E of 11.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Globe Life Inc. sells life insurance, supplemental health insurance, and annuities, earning money primarily through insurance premium revenue and through its Investments segment.
Globe Life's profit engine links (1) premium revenue from its Life and Supplemental Health products to underwriting profitability, while (2) its Annuities and Investments businesses translate premiums and reserves into investment returns.
| Life | $0.8B |
| Health | $0.4B |
| Annuities | $0.3B |
| Investments | $0.0B |
Business quality (Solid): Clear product-led structure (Life, Supplemental Health, Annuities, Investments) with premium revenue metrics available, but the provided facts do not show how much revenue comes specifically from Annuities and Investments, limiting how precisely investors can underwrite the profit model.
Valuation: At 12× earnings, GL trades in line with the Insurance average (13×). Note: one-time items can distort reported P/E.
| Price | $173.08 |
| Market Cap | $13.30B |
| P/E Ratio | 11.0 |
| EV / EBITDA | 10.7 |
| Price / Book | 2.16 |
| Price / Sales | 2.15 |
| FCF Yield | 9.3% |
| DCF Value (model) | $290.71 |
| DCF Upside vs Price | 68.0% |
| Revenue (TTM) | $5.99B |
| Net Margin | 19.4% |
| Revenue Growth (YoY) | 8.0% |
| EPS Growth (YoY) | 20.1% |
| FCF Growth (YoY) | 0.9% |
| Stock P/E | 11.0 |
| Sector P/E (Financials) | 15.2 |
| Industry P/E (Insurance) | 13.1 |
| vs Sector | -27.9% |
| vs Industry | -16.0% |
| Top Institutional Holder | VANGUARD GROUP INC ($1.41B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 6 |
| Sector | Financials |
| Industry | Insurance |
| CEO | Frank Martin Svoboda |
| Employees | 3,732 |
| Country | US |
| IPO Date | 1980-10-01 |
Data as of 2026-08-24.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.